In a recent development, DRDO released a statement saying that its lab has developed an antibody detection-based kit DIPCOVAN, the DIPAS-VDx COVID 19 IgG Antibody Microwell ELISA for sero-surveillance.
The kit can detect spike as well as nucleocapsid (S&N) proteins of SARS-CoV-2 virus with a high sensitivity of 97% & specificity of 99%, added DRDO.
It’s been developed in association with Vanguard Diagnostics Pvt Ltd, a Delhi based development & manufacturing diagnostics company, it said.
DRDO further said that it was developed indigenously by scientists, followed by extensive validation on over 1000 patient samples at various COVID hospitals in Delhi.
3 batches of product were validated during last one year. Antibody detection kit is approved by ICMR in April 2021. In May 2021, the product received the regulatory approval from the DCGI, CDSCO, Ministry of Health & Family Welfare, to manufacture for sale & distribution, ANI reported quoting DRDO.
Explore the profound effects of excessive screen time on your child’s behavior and development. Discover…
Discover how simple daily changes in your diet and lifestyle can significantly improve your heart…
This article explores the common misconception that brain tumours primarily affect older adults, revealing the…
The first-ever ovarian cancer vaccine is poised to change the landscape of women's health by…
As dengue and chikungunya cases rise in Delhi during the monsoon season, understanding prevention strategies…
Skincare is a significant concern for women (and increasingly, men), with the quest for perfect,…